A61M2205/27

INHALER, ASSEMBLY AND METHOD FOR INHALING INHALATION MEDIUM ENRICHED WITH ACTIVE INGREDIENTS AND/OR AROMATIC SUBSTANCES, AND METHOD FOR CONTROLLING AN INHALER
20230158256 · 2023-05-25 ·

An inhaler configured and adapted for inhaling an inhalation medium, enriched with active ingredients and/or flavouring substances, includes a cartridge carrier, a storage tank which contains the inhalation medium, a mouthpiece which is associated with the cartridge carrier, and an actuating mechanism for releasing the inhalation medium out of the storage tank in the direction of the mouthpiece. The inhaler has at least one sensor associated with the mouthpiece. The sensor is configured and adapted to detect characteristics of lips of the person using the inhaler and to provide a data signal formed from the characteristics. The sensor is connected to an electronic control unit associated with the inhaler, to which the actuating mechanism is also connected, in such a manner that the inhalation medium is released on the basis of the data signal. A corresponding arrangement and a corresponding method are disclosed.

Inner housing for a drug delivery device
11654243 · 2023-05-23 · ·

A dose setting mechanism for a drug delivery device is disclosed. The mechanism comprises an outer housing and an inner housing having an external groove. The inner housing guides a driver to dispense a set dose. A dial sleeve is disposed between the outer and inner housing and is rotatably engaged with the inner housing. When a dose is set, the dial sleeve is rotated and translates away from both the outer housing and the inner housing.

Inhaler system

Provided is a system including a plurality of inhalers that each include a processor configured to determine a value of a usage parameter relating to use of the respective first inhaler, encrypt data based on the value, and transmit the encrypted data. At least two of the inhalers include different medicament, such as a rescue medicament and a maintenance medicament. The system includes an external device that includes a processor configured to distinguish between the encrypted data of each respective inhaler, determine respective usage information relating to each of the distinct types of medicament based on the respective encrypted data, and control a user interface (e.g., of the external device) to communicate the usage information related to each inhaler and/or each respective type of medicament.

ELECTRONICALLY-CONTROLLED CAPTURING SYSTEM FOR DRUG DELIVERY SYSTEMS

An electronically-controlled capturing system for capturing data representing an amount of a drug expelled or discharged from a drug reservoir includes an electronic circuit including an electric energy unit, a processing unit operable by electric power obtained from the electric energy unit and operable to acquire data, and an electronic storage unit connected to the processing unit and configured to store the acquired data. The processing unit is operable to write the acquired data in the storage unit and is operable to read and provide the stored data from the electronic storage unit. The capturing system also includes a data reading disabling unit operably connected to the processing unit , the electronic storage unit and/or the electric energy unit. The data reading disabling unit is switchable into an activated state, in which the data reading disabling unit persistently prevents readout or providing of stored data from the electronic storage unit.

SOLUTION VERIFICATION PRIOR TO THERAPY IN RENAL INSUFFICIENCY TREATMENT
20230106252 · 2023-04-06 ·

Systems and methods for renal insufficiency treatment that include identifying and associating a solution container with a container support in the systems and methods are described herein. The systems and methods may associate an identified solution with an identified container support and verify compatibility of that combination with a selected treatment to reduce the likelihood for errors during setup and use of the systems and methods.

INHALATION DEVICE, METHOD, AND PROGRAM

The present invention provides an inhalation device with which it is possible to improve usability and promote users' safety and satisfaction with the inhalation device. An inhalation device according to the present invention is provided with a first member and a second member which is configured to be capable of being attached to and detached from the first member. This inhalation device includes: an active functional part which is provided to the first member; a passive functional part which is provided to the second member and which is capable of changing the state thereof according to the working of the active functional part; a sensor part which is provided to the first member and which detects a changed state of the passive functional part; and a control part which, on the basis of the detected state, determines whether the second member has been attached to the first member.

PORTABLE NEBULIZER AND VERTICAL-TYPE MEDICINE CONTAINING AND NEBULIZING ASSEMBLY THEREOF
20230144185 · 2023-05-11 ·

A portable nebulizer and a vertical-type medicine containing and nebulizing assembly thereof are provided. The vertical-type medicine containing and nebulizing assembly includes a medicine storage module, a nebulizing module and an induction module. The nebulizing module includes a nebulizing device and a first conductive structure. The induction module includes a metal induction element disposed in the medicine storage module and a second conductive structure electrically connected to the metal induction element. The medicine storage casing has an inner surrounding area located in the medicine storage space. The metal induction element has an exposed induction portion exposed on the inner surrounding area for receiving a signal generated by the nebulizing device. Therefore, when a predetermined medicinal liquid contained in the medicine storage space is nebulized through the nebulizing device, the signal generated by the nebulizing device can be transmitted to a microprocessor through the induction module.

Mobile inhaler for substance delivery

A mobile inhaler includes a power source, at least one aerosolization system, an aerosolization system control component, and a data transmission component. Each aerosolization system includes at least one reservoir, and each of the at least one reservoir is configured for holding a liquid to be aerosolized. The mobile inhaler father includes a fault detection component configured for detecting a fault, for at least one of deactivating the at least one aerosolization system and deactivating the power source, and for operating based on a temperature.

System and method for controlling a self-injector device
09844628 · 2017-12-19 ·

A cartridge-based computer controlled self-injection device automatically regulates time and dosage administered to a patient. Cartridges can be electronically tagged so the injection device can determine the content, volume, expiration date, and physician prescribed dosage timetable. Authentication verifies the device and ensures the proper patient is using the device with the appropriate therapeutic injectant. Authentication further provides information controlling device operation including expiration dates and clock synchronization. Therapeutic injectant administration statistics, such as date and time of administration of a therapeutic injectant are stored and provide to a health care provider for monitoring. Patients can be notified of nearing or missed administrations.

HEART RATE MONITOR FOR AN AEROSOL DELIVERY DEVICE

An aerosol delivery device includes at least one housing structured to retain an aerosol precursor composition, and an atomizer. A microprocessor is configured to operate in an active mode in which the control body is configured to control the atomizer to activate and produce an aerosol from the aerosol precursor composition. A heart rate monitor is configured to obtain biopotential measurements from a user, the biopotential measurements forming an identifier of the user. The microprocessor is operably coupled with the heart rate monitor and is configured to perform a biometric authentication of the user based on the identifier, and to control operation of at least one functional element of the aerosol delivery device based on the biopotential measurements, with the controlling operation of at least one functional element including altering a locked state of the aerosol delivery device based on the biometric authentication.